JMP Securities Reiterates Market Outperform Rating for Structure Therapeutics (NASDAQ:GPCR)
Structure Therapeutics (NASDAQ:GPCR – Get Free Report)‘s stock had its “market outperform” rating reissued by equities research analysts at JMP Securities in a research note issued to investors on Monday,Benzinga reports. They presently have a $89.00 target price on the stock. JMP Securities’ target price would suggest a potential upside of 297.68% from the stock’s […]
Structure Therapeutics (NASDAQ:GPCR – Get Free Report)‘s stock had its “market outperform” rating reissued by equities research analysts at JMP Securities in a research note issued to investors on Monday,Benzinga reports. They presently have a $89.00 target price on the stock. JMP Securities’ target price would suggest a potential upside of 297.68% from the stock’s […]
